Cold-Pressed Hazelnut Oil (Corylus avellana)

Cold-pressed hazelnut oil (Corylus avellana) is a seed oil rich in oleic acid (typically 75–85% of fatty acid profile) and tocopherols, particularly alpha-tocopherol, which act as lipid-soluble antioxidants. Its high unsaturated fatty acid content and squalene content have been studied primarily in vitro and in animal models, with no confirmed clinical benefits in human trials to date.

Category: Seed Oils Evidence: 2/10 Tier: Emerging
Cold-Pressed Hazelnut Oil (Corylus avellana) — Hermetica Encyclopedia

Origin & History

Cold-pressed hazelnut oil is derived from the kernels of Corylus avellana trees, with Turkey being a major supplier. The oil is extracted through low-temperature cold-pressing of shelled hazelnuts, yielding an oil rich in unsaturated fatty acids (over 90%), primarily oleic acid (~77.8%) and linoleic acid (~10.1%).

Historical & Cultural Context

No historical or traditional medicinal uses were documented in the provided research sources. The available literature focuses solely on the oil's chemical composition and extraction methods.

Health Benefits

• No clinical health benefits documented - no human trials identified in research
• Contains high levels of unsaturated fatty acids (>90%) - preliminary evidence only
• Rich in tocopherols and phenolic compounds - no clinical evidence for health effects
• Contains squalene and sterols - biochemical composition only, no health studies
• Cold-pressed processing preserves natural compounds - manufacturing benefit only, no clinical data

How It Works

Oleic acid, comprising up to 85% of hazelnut oil's fatty acid profile, may modulate membrane fluidity and influence NF-κB signaling pathways, potentially reducing pro-inflammatory cytokine expression in vitro. Alpha-tocopherol neutralizes lipid peroxyl radicals by donating a hydrogen atom, interrupting chain reactions in cell membranes, while phenolic compounds such as caffeic acid and quercetin derivatives may inhibit cyclooxygenase (COX) enzymes. Squalene, a triterpene precursor to cholesterol biosynthesis, has shown HMG-CoA reductase-adjacent activity in biochemical studies, though these pathways have not been validated in human supplementation trials.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses on cold-pressed hazelnut oil were identified in the available research. No PubMed PMIDs are available as no clinical studies were found in the provided sources.

Clinical Summary

No published randomized controlled trials or prospective human studies have specifically evaluated cold-pressed hazelnut oil as a dietary supplement for health outcomes. Most available evidence derives from in vitro cell culture studies and compositional analyses confirming its high oleic acid (75–85%), tocopherol (up to 47 mg/100g), and squalene (up to 0.6 mg/g) content. A small number of animal studies have explored its antioxidant capacity and lipid-profile modulation, but these findings have not been replicated in human populations. Given the absence of clinical trials, any health claims for hazelnut oil supplementation are considered preliminary and evidence-based conclusions cannot currently be drawn.

Nutritional Profile

Cold-pressed hazelnut oil is a pure lipid extract with approximately 99.9% total fat content and negligible protein, carbohydrate, and fiber. Per 100g: total fat ~99g, with a fatty acid profile dominated by oleic acid (monounsaturated omega-9, ~75-83%), followed by linoleic acid (polyunsaturated omega-6, ~8-15%), palmitic acid (saturated, ~4-7%), and stearic acid (saturated, ~1-3%). Alpha-linolenic acid (omega-3) is present only in trace amounts (<0.2%), yielding a high omega-6:omega-3 ratio. Vitamin E content is notable, primarily as alpha-tocopherol (~25-47mg/100g) and gamma-tocopherol (~2-10mg/100g), placing it among moderately high tocopherol-containing oils; cold-pressing preserves these compounds more effectively than refining. Phenolic compounds including caffeic acid, ferulic acid, and quercetin derivatives are present at low concentrations (~50-200mg/kg total polyphenols), with bioavailability from an oil matrix considered low due to their partial hydrophilic nature. Squalene is detected at approximately 50-150mg/100g. Phytosterols total roughly 100-150mg/100g, primarily beta-sitosterol (~70-100mg/100g), campesterol (~10-20mg/100g), and stigmasterol (~5-15mg/100g). Caloric density is approximately 884 kcal/100g. Bioavailability of fatty acids is high given the liquid oil matrix; fat-soluble tocopherols are readily co-absorbed with dietary fat, while polar phenolics in an oil matrix have limited but not negligible absorption.

Preparation & Dosage

No clinically studied dosage ranges are available as no clinical trials have been conducted on cold-pressed hazelnut oil. Forms and standardization details are not documented in the research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other cold-pressed nut oils, vitamin E, omega fatty acid supplements, antioxidant compounds

Safety & Interactions

Hazelnut oil is contraindicated in individuals with tree nut allergies, particularly hazelnut (Corylus avellana) allergy, as cross-reactive proteins may persist in cold-pressed oils and trigger IgE-mediated reactions. No documented drug interactions with pharmaceutical agents have been established in peer-reviewed literature, though its high vitamin E (alpha-tocopherol) content theoretically could potentiate anticoagulant effects of warfarin at very high supplemental doses. Safety data during pregnancy and lactation is insufficient, and use as a therapeutic supplement during these periods should be deferred until clinical evidence is available. Topical application is generally regarded as low-risk in non-allergic individuals, though oral supplement safety at concentrated doses remains unstudied.